The Pharma Data

DECEMBER 15, 2020

Under the agreement, Aurena Laboratories will establish a production unit to meet the regulatory requirements for the manufacture of Lipidor’s pharmaceutical products. This will enable Lipidor to offer potential licensees the opportunity for large-scale commercial production.

Contract Manufacturing 52

Contract Manufacturing Manufacturing Production Drugs 52

Roots Analysis

JANUARY 15, 2024

Requirement of higher biopharmaceutical manufacturing capacity products owing to the increasing demand for such drugs. Advanced and complex technologies are required for manufacturing, as well as testing of biopharmaceuticals.

Contract Manufacturing 40

Contract Manufacturing Manufacturing Production Development 40

Pharmaceutical Technology

SEPTEMBER 8, 2022

Streamlined development, flexibility in manufacturing, and improved product quality at reduced costs, while gaining access to capabilities and capacity are some of the factors fuelling the pharmaceutical solid dosage contract manufacturing market.

Manufacturing 100

Manufacturing Marketing Contract Manufacturing Containment 100

Pharmaceutical Technology

SEPTEMBER 14, 2022

The growing demand for innovative drugs and a limited number of blockbuster drugs has led to the growth of the pharmaceutical contract manufacturing market, which has fuelled contract commercial dose manufacturing and marketing. Contract marketing of commercial doses.

Marketing 100

Marketing Contract Manufacturing Manufacturing Containment 100

Pharmaceutical Technology

AUGUST 10, 2022

Working with a contract manufacturing organization (CMO) in the pursuit of bringing a new product to market can deliver a range of significant benefits. They are also likely to have already worked with a similar molecule and can even anticipate the hurdles a company may face in production. Proven results??.

Contract Manufacturing 130

Contract Manufacturing Manufacturing Production Packaging 130

Pharmaceutical Technology

SEPTEMBER 20, 2022

Clinical packaging and labelling follow stringently controlled procedures and high-standard quality control measures to assure the safety and functionality of investigational medicinal products, during their storage, distribution, and use. Clinical trial packaging and labelling solutions.

Packaging 100

Packaging Packaging Marketing Clinical Trials 100

Pharmaceutical Technology

SEPTEMBER 14, 2022

Pharmaceutical drug research and development (R&D) activities are capital-intensive, which makes the outsourcing of clinical dose manufacturing and marketing popular. Pharmaceutical Technology has listed the top clinical dose companies in contract marketing based on our intel, insights and decades-long experience in the sector.

Marketing 100

Marketing Contract Manufacturing Sales Clinical Trials 100

Pharmaceutical Technology

JULY 29, 2022

Pfizer (New York, New York) and Moderna’s (Cambridge, Massachusetts) Omicron-specific Covid-19 vaccines are in late-stage development, have demonstrated good efficacy against the variant and will likely be available to the public later this year to provide an additional booster and increase demand for injectable manufacturing.

Manufacturing 130

Manufacturing Vaccine Vaccination Packaging 130

Pharmaceutical Technology

NOVEMBER 25, 2022

All evidence indicated that containment in facilities is in high demand and will be increasingly so in the future as the oncology pipeline and the use of cytotoxic drugs continues to grow. Dedicated manufacturers are investing heavily in these services, powered by client requirements.

Manufacturing 130

Manufacturing Containment Contract Manufacturing Development 130

Roots Analysis

AUGUST 29, 2024

As such there are several factors which will continue to drive radiopharmaceutical production market. Radiopharmaceutical Production Market The production of radiopharmaceuticals typically requires a specific set of components, including a radionuclide generator and a radiopharmaceutical precursor.

Production 52

Production Marketing Manufacturing Contract Manufacturing 52

Roots Analysis

APRIL 15, 2024

Further, the manufacturing of biologics fill finish is a highly complex and cost-intensive process. Notable examples of fill finish manufacturing companies equipped with SA25 aseptic filling workstation include ( in alphabetical order ) Emergent Bioservices, PCI Pharma Services, Singota Solutions and WuXi Biologics.

Manufacturing 40

Manufacturing Production Contract Manufacturing Contamination 40

Pharmaceutical Technology

JANUARY 12, 2023

– about the advantages and challenges of product lyophilization, developing lyophilization processes on site at their Bloomington, Indiana plant, and the importance of continuing research. Biologics often have strict temperature requirements to ensure the product remains stable. KB: Primarily stability.

Production 130

Production Contamination Development Manufacturing 130

Pharmaceutical Technology

APRIL 12, 2023

The ingredients used in these drugs are high potency, even at small doses, and pose a risk to both human health and cross-contamination with other drugs in a manufacturing environment. Currently mostly outsourced, there are signs that CMOs are beginning to make investments in containment capabilities, to capture emerging opportunities.

Manufacturing 130

Manufacturing Production Containment Contamination 130

pharmaphorum

JANUARY 19, 2021

As vaccine manufacturers face unprecedented demand for their newly approved products, the race is on to provide enough shots for billions of people across the world. Pfizer and BioNTech have responded to this by upgrading their manufacturing facility in Puurs, Belgium.

Vaccine 89

Vaccine Vaccination Manufacturing Contract Manufacturing 89

Roots Analysis

DECEMBER 11, 2022

Antibody drug conjugates market is presently an established therapeutic concept with 11 approved products. What is the need for outsourcing ADC production? ADC manufacturing is a time-consuming process fraught with a number of challenges; this necessitates ADC developers to outsource operations to contract service providers.

Antibody 40

Antibody Marketing Contract Manufacturing Drugs 40

Pfizer

JANUARY 17, 2023

Pfizer to Acquire Sanford, North Carolina Manufacturing Site from Abzena. Share. • State-of-the-art biologics drug substance facility will produce Pfizer’s innovative pipeline products and provide additional capacity for in-line medicines. • Expected to more than double the current workforce of new facility by 2025.

Manufacturing 85

Manufacturing Containment Development Medicine 85

Roots Analysis

FEBRUARY 15, 2022

Given the fact that ADCs are highly potent cytotoxic molecules, the manufacturing of ADCs requires elaborate technical capabilities and highly potent chemical substances. However, several ADC developers do not have the in-house capabilities to manufacture cytotoxic payload on a commercial scale and tend to rely on contract manufacturers.

Contract Manufacturing 52

Contract Manufacturing Manufacturing Marketing Containment 52

Roots Analysis

FEBRUARY 13, 2023

The key applications of mRNAs are below: Contract Manufacturing in mRNA Synthesis AND Manufacturing Service Domain The synthesis and manufacturing process of mRNA-based therapeutics / vaccines is complex and associated with several challenges.

Manufacturing 52

Manufacturing Drug Delivery Systems Genetic Engineering RNA 52

FDA Law Blog

JANUARY 1, 2024

Four of the letters addressed failure to comply with drug Current Good Manufacturing Practice regulations, four more stated that the recipients were distributing unapproved drug products, two alleged violations of the Quality System Regulation by medical device manufacturers, and one was addressed to a clinical investigator.

Manufacturing 59

Manufacturing Production Drugs Contract Manufacturing 59

The Pharma Data

OCTOBER 22, 2021

Subject to reaching a final agreement, Novartis plans to transfer the manufacturing process from Stein to Ljubljana point to commence the filler and finish in the first half of 2022. This new agreement follows a first contract inked before this time. The specifics will be bared when we conclude specific agreements.

Vaccine 52

Vaccine Vaccination Filler Manufacturing 52

Roots Analysis

OCTOBER 24, 2023

Owing to the advancement in clinical pharmacology and oncology domain, and the rising demand for targeted therapeutics and precision medicines, high potency active pharmaceutical ingredients (HPAPIs) and cytotoxic drugs have become one of the key areas of interest to researchers and drug manufacturers across the globe.

Manufacturing 40

Manufacturing Hormones Contamination Containment 40

The Pharma Data

AUGUST 7, 2020

to manufacture and supply Gilead’s investigational antiviral remdesivir, as one of multiple external manufacturing organizations supporting efforts to scale up supply of the investigational treatment for COVID-19. Pfizer Disclosure Notice: The information contained in this release is as of August 7, 2020.

Manufacturing 52

Manufacturing Containment Contract Manufacturing Development 52

The Pharma Data

SEPTEMBER 11, 2021

Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. This press release contains forward-looking statements. Source link: [link].

Antibody 52

Antibody DNA Containment Manufacturing 52

XTalks

FEBRUARY 11, 2021

Pfizer is planning to reduce that time to an average of 60 days, cutting production time by almost 50 percent. For Pfizer-BioNTech’s vaccine, a batch consists of between one and three million doses of vaccine per production run. This in light of Pfizer having upped its production goal to two billion COVID-19 vaccine doses this year.

Manufacturing 52

Manufacturing Vaccine Vaccination DNA 52

The Pharma Data

JANUARY 27, 2021

MultiStem ® cell therapy is a patented regenerative medicine product candidate in clinical development that has shown the ability to promote tissue repair and healing in a variety of ways, such as through the production of therapeutic factors in response to signals of inflammation and tissue damage. About MultiStem ®.

Clinical Trials 52

Clinical Trials Clinical Trials Production Trials 52

The Pharma Data

NOVEMBER 2, 2020

added to their Amazon professional use product offerings,” said CEO Keith Berman. is the leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters. ABOUT DECISION DIAGNOSTICS CORP Decision Diagnostics Corp. million diabetics worldwide. Two of the company’s.

Manufacturing 40

Manufacturing Contract Manufacturing Production Engineer 40

The Pharma Data

JANUARY 27, 2021

As a bioscience accelerator at the leading-edge of the life science industry, XPhyto targets growth through commercialization of its product pipeline and focused investment in impact driven innovation with the potential for meaningful value creation. . VANCOUVER, BC / ACCESSWIRE / January 28, 2021 / XPhyto Therapeutics Corp.

Drugs 52

Drugs Manufacturing Drug Delivery Production 52

The Pharma Data

JANUARY 5, 2021

Since 2018, Novasep and Sartorius have been collaborating in the joint development of an optimized system for a membrane-based, low-pressure chromatography that processes larger molecules more productively and that will be launched soon.

Life Science 40

Life Science Manufacturing Sales Contract Manufacturing 40

The Pharma Data

JULY 21, 2021

Biovac will obtain drug substance from facilities in Europe, and manufacturing of finished doses will commence in 2022. At full operational capacity, the annual production will exceed 100 million finished doses annually. All doses will exclusively be distributed within the 55 member states that make up the African Union.

Vaccine 52

Vaccine Vaccination Manufacturing Clinical Trials 52

Pharmaceutical Technology

JULY 4, 2022

Russia is an already insular country and its worldview has tended to be self-contained, but this has hardened in the face of recent sanctions and counter-sanctions imposed during the war with Ukraine. Russian pharma company R-Pharm (Moscow, Russia) had set up a production facility in Illertissen, Bavaria, to produce the vaccine.

Pharma Production 305

Pharma Production Production Clinical Trials Clinical Trials 305

The Pharma Data

JANUARY 5, 2021

Since 2018, Novasep and Sartorius Stedim Biotech have been collaborating in the joint development of an optimized system for a membrane-based, low-pressure chromatography that processes larger molecules more productively and will be launched soon.

Manufacturing 40

Manufacturing Sales Contract Manufacturing Insulin 40

The Pharma Data

NOVEMBER 15, 2020

MultiStem ® cell therapy is a patented regenerative medicine product candidate in clinical development that has shown the ability to promote tissue repair and healing in a variety of ways, such as through the production of therapeutic factors in response to signals of inflammation and tissue damage. About MultiStem ®.

Clinical Trials 40

Clinical Trials Clinical Trials Production Trials 40

The Pharma Data

JANUARY 24, 2021

Therma Bright is also in the process of identifying component suppliers to be used in the large-scale manufacturing of the SCV2 test and is identifying contract manufacturers to manufacture and assemble the final product. We will report back on the prospective study sites in the near future.” About SCV2.

Sales 40

Sales Manufacturing Contract Manufacturing Containment 40

The Pharma Data

JANUARY 5, 2021

It increases the optionality to the Company’s value proposition, leverages our endocrine expertise and adds a late-stage pivotal trial-ready orphan disease product to the existing Phase 3 programs for abaloparatide and elacestrant,” said Radius Chief Executive Officer, Kelly Martin. RAD011 has the potential for broad clinical applicability.

Manufacturing 52

Manufacturing FDA Approval Trials Development 52

The Pharma Data

NOVEMBER 5, 2020

Key Pipeline Progress Regeneron has more than 20 product candidates in clinical development, including five marketed products for which it is investigating additional indications. In July 2020 , the Company announced an agreement whereby the Company was awarded a $450 million contract to manufacture and supply REGN-COV2 to the U.S.

Sales 40

Sales Production Manufacturing Antibody 40

The Pharma Data

MAY 4, 2021

Multiple innovative and biosimilar products across our portfolio delivered growth, demonstrating the strength of our business and the depth and breadth of our growth drivers. This guidance may be adjusted in the future as additional contracts are executed. Hospital products, which grew 10% operationally to $2.3

Vaccination 40

Vaccination Vaccine Production Sales 40

The Pharma Data

DECEMBER 23, 2020

The advantages of INOVIO’s DNA medicine platform are how fast DNA medicines can be designed and manufactured; the stability of the products, which do not require freezing in storage and transport; and the robust immune response, safety profile, and tolerability that have been observed in clinical trials.

DNA 40

DNA Vaccination Vaccine Immune Response 40